Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Bafna Pharmaceuticals Ltd - 532989 - Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ending 31St Dec 2018 And Other Business Matters

 BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2019 ,inter alia, to consider and approve Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, 08th February 2019 at the registered office of the Company, to inter alia consider and adopt un-audited financial results for the quarter ended 31st December 2018 and any other business with the permission of the Chair.
31-01-2019
Bigul

BAFNA PHARMACEUTICALS LTD. - 532989 - Shareholding for the Period Ended December 31, 2018

 Bafna Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here
19-01-2019
Bigul

BAFNA PHARMACEUTICALS LTD. - 532989 - Statement Of Investor Complaints For The Quarter Ended December 2018

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0550 Name of the Signatory :- JITENDRA KUMAR PALDesignation :- Company Secretary and Compliance Officer
19-01-2019
Bigul

Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)

 Sub.:- Appointment of Mr. Radhakrishnan Dharmarajan as Resolution Professional (RP) and Relieve of Mr. Gopalsamy Ganesh Babu as IRP We would like to inform you that Mr. Radhakrishnan Dharmarajan has been appointed as Resolution Professional (RP) and Mr. Gopalsamy Ganesh Babu has been relieved as IRP vide Order Passed by National Company Law Tribunal, Single Bench, Chennai dated 11th...
24-11-2018
Bigul

Result For 30Th Sep 2018

 We would like to inform you that the Board at its meeting held on today approved the un-audited financial results for the quarter / half year ending 30th September 2018. Please find attached the un-audited financial results for quarter / half year ending 30th September 2018 along with the Limited Review Report obtained from the statutory auditor of the Company. The meeting commenced at 3.00 PM and concluded at 6.45 P.M
13-11-2018
Bigul

Board Meeting Intimation for Intimation Of Board Meeting Of The Company To Inter-Alia Consider And Approve The Un-Audited Financial Results For The Quarter Ending 30Th Sep 2018

 BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2018 ,inter alia, to consider and approve Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Tuesday, 13th November 2018 at the registered office of the Company, to inter alia consider and adopt un-audited financial results for the quarter ended 30th Sep 2018 and any other business with the permission of the Chair.
05-11-2018
Bigul

Ref: Regulation 40(9) Of The SEBI (LODR) Regulations, 2015

 Certificate from Practicing Company Secretary under Regulation 40(9) of SEBI (LODR) Regulations, 2015 for the half year ended 30th September 2018 is hereby enclosed for your reference.
24-10-2018
Bigul

Shareholding for the Period Ended September 30, 2018

 Bafna Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here
16-10-2018
Bigul

Statement Of Investor Complaints For The Quarter Ended September 2018

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Jitendra Kumar PalDesignation :- Company Secretary and Compliance Officer
16-10-2018
Bigul

Compliance Certificate For The Half Year Ended 30Th Sep 2018

 Compliance Certificate certifying maintenance of physical and electronic transfer facility under Regulation 7(3) of SEBI (LODR) Regulations, 2015 for the half year ended 30th Sep 2018 is hereby enclosed for your reference.
11-10-2018
Next Page
Close

Let's Open Free Demat Account